quarta-feira, 7 de outubro de 2026
PesquisarExplore
pt.VIA.NEWS
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· May 21, 2026

Stocks Rebound as Crude Oil Falls on Hopes for a US-Iran Deal

View original at nasdaq.com
Stocks Rebound as Crude Oil Falls on Hopes for a US-Iran Deal The S&P 500 Index ($SPX) (SPY) on Thursday closed up +0.17%, the Dow Jones Industrial Average ($DOWI) (DIA) closed up +0.55%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed up +0.20%…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Enriched uranium must stay in Iran, as sending the material abroad would leave the country more vulnerable to future attacks by the US and Israel

    60% confidence

  • He called off a strike on Iran scheduled for Tuesday after Gulf allies asked for more time to give diplomacy a chance

    60% confidence

  • There are some good signs that a deal with Iran could be reached

    60% confidence

  • The latest US proposal has narrowed the gaps between the two sides

    60% confidence

  • The current disruption has drawn down nearly 500 million bbl from global crude stockpiles, with the drawdown potentially reaching 1 billion bbl by June

    60% confidence

  • Kroger is considering significant price cuts to win back market share

    60% confidence

  • Q1 S&P 500 earnings are projected to climb +12% y/y

    60% confidence

  • The employment side of the Fed's dual mandate is mostly stable, but right now there is a pretty significant inflation problem developing

    60% confidence

  • Global oil inventories declined at a rate of about 4 million bpd in March and April, and the market will remain severely undersupplied until October even if the conflict ends next month

    60% confidence
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
A nossa leitura dos dados ›
Sinais que acompanhamos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Padrões que observamos ›
Onde as fontes divergem
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,985
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,985 factos verificados com a fonte5,351 documentos-fonte arquivados
Consulte estes dados → isubstrate.com
Stocks Rebound as Crude Oil Falls on Hopes for a US-Iran Deal — Source | Via News | pt.VIA.NEWS